Narwhal Capital Management’s Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an HIMS.WS Stock Holding History

Narwhal Capital Management’s Portfolio HIMS.WS Stock Details HIMS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,000	Closed	-$101K	–	179
2021 Q2	$101K	Hold	30,000	–	–	0.01%	163
2021 Q1	$132K	Buy	+30,000	New	+$196K	0.02%	154

Narwhal Capital Management's HIMS.WS Position: Q3 2021 in Review

Narwhal Capital Management sold out of Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) in Q3 2021, closing a stake of 30,000 shares — an estimated $101K sold.

Narwhal Capital Management first reported a position in HIMS.WS in Q1 2021 and held it in 2 quarters. The position peaked at $132K in Q1 2021. 0 funds tracked by Wall St. Rank hold HIMS.WS as of Q3 2021.

Narwhal Capital Management reported no remaining Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position as of Q3 2021 after selling out during the quarter.
Narwhal Capital Management sold 30,000 Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an shares in Q3 2021, an estimated $101K.
Narwhal Capital Management first reported a position in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an in Q1 2021 and held it in 2 quarters.
Narwhal Capital Management's Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position peaked at $132K in Q1 2021.
0 funds tracked by Wall St. Rank held Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an as of Q3 2021.

Based on Narwhal Capital Management's 13F filing for Q3 2021, filed 22 Oct 2021.